Newly listed stock N Tainuo-U jumped 246.82% at the open; its prospectus says the company develops blood-product substitute therapies.

2026-07-21

Newly listed stock N Tainuo-U jumped 246.82% at the open; its prospectus says the company develops blood-product substitute therapies.